Enganding®-cosunter

Enganding®【Entecavir Capsules】

[Name of Drug] Commercial name: Enganding General name: Entecavir Capsules [Description] White or almost white granules or powders [Indication] Applicable to adult hepatitis B patients with active virus replication, continuous increase in serum transaminase (ALT) or histological active lesion in the liver. [Application & Dosage] Taken orally on an empty stomach (2h ante or post cibum), once a day, 0.5mg each time for adults and teenagers of 16 years old or above, and 1.0mg each time for patients with viremia in lamivudine treatment. [Specification] 0.5mg [Storage] Protected from light and preserved in dry place under 25℃ below, tightly sealed.

Generic name：	Entecavir Capsules	Commodity name：	Enganding®
English name：	Entecavir Capsules	Chinese name：	Enganding
character：	White or almost white granules or powders	Specifications：	0.5mg
component：
indication：	Applicable to adult hepatitis B patients with active virus replication, continuous increase in serum transaminase (ALT) or histological active lesion in the liver.
usage and dosage：	Taken orally on an empty stomach (2h ante or post cibum), once a day, 0.5mg each time for adults and teenagers of 16 years old or above, and 1.0mg each time for patients with viremia in lamivudine treatment.
Adverse reactions：
taboo：
matters needing attention：
Medication for pregnant women：
Medication for the elderly：
Medication for children：
Drug action：
Drug overdose：
Drug toxicology：
Approval number：	国药准字H20110172